Aramark (NYSE:ARMK)’s traded shares stood at 40.66 million during the last session, with the company’s beta value hitting 1.67. At the close of trading, the stock’s price was $33.67, to imply an increase of 0.33% or $0.11 in intraday trading. The ARMK share’s 52-week high remains $45.72, putting it -35.79% down since that peak but still an impressive 14.64% since price per share fell to its 52-week low of $28.74. The company has a valuation of $9.09B, with an average of 4.92 million shares in intraday trading volume over the past 10 days and average of 3.11 million shares over the past 3 months.
Aramark (NYSE:ARMK) trade information
After registering a 0.33% upside in the last session, Aramark (ARMK) has traded red over the past five days. The stock hit a weekly high of 34.78 this Friday, 03/17/23, jumping 0.33% in its intraday price action. The 5-day price performance for the stock is -2.66%, and -13.53% over 30 days. With these gigs, the year-to-date price performance is -18.55%. Short interest in Aramark (NYSE:ARMK) saw shorts transact 10.37 million shares and set a 4.84 days time to cover.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
Aramark (ARMK) estimates and forecasts
Looking at statistics comparing Aramark share performance against respective industry, we note that the company has outperformed competitors. Aramark (ARMK) shares are -11.23% down over the last 6 months, with its year-to-date growth rate higher than industry average at 55.17% against 7.10%. Revenue is forecast to grow 50.00% this quarter before jumping 56.00% for the next one. The rating firms project that company’s revenue will grow 11.90% compared to the previous financial year.
Revenue forecast for the current quarter as set by 9 analysts is $4.41 billion. Meanwhile, for the quarter ending Jun 2023, a total of 9 analyst(s) estimate revenue growth to $4.54 billion.Earnings reports from the last fiscal year show that sales brought in $3.86 billion and $4.13 billion respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 14.10% before jumping 9.90% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -12.80% for the past 5-year period. While 2023 is set for a 286.00% return in earnings, projections for the next 5 years are at 31.80% annually.
ARMK Dividends
Aramark has its next earnings report out between May 08 and May 12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Aramark has a forward dividend ratio of 0.44, with the share yield ticking at 1.31% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Aramark (NYSE:ARMK)’s Major holders
Aramark insiders hold 0.89% of total outstanding shares, with institutional holders owning 106.21% of the shares at 107.17% float percentage. In total, 106.21% institutions holds shares in the company, led by Vanguard Group, Inc. (The). As of Sep 29, 2022, the company held over 23.76 million shares (or 9.20% of shares), all amounting to roughly $741.27 million.
The next major institution holding the largest number of shares is Capital International Investors with 19.86 million shares, or about 7.69% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $619.6 million.
We also have American Funds Insurance Ser-Asset Allocation Fund and Eaton Vance Atlanta Capital SMID-Cap Fd as the top two Mutual Funds with the largest holdings of the Aramark (ARMK) shares. Going by data provided on Dec 30, 2022, American Funds Insurance Ser-Asset Allocation Fund holds roughly 11.38 million shares. This is just over 4.40% of the total shares, with a market valuation of $470.25 million. Data from the same date shows that the other fund manager holds a little less at 10.79 million, or 4.18% of the shares, all valued at about 336.57 million.